FEBS3+ Conference of
Estonian, Latvian and Lithuanian Biochemical Societies

Tallinn, Estonia
   | 15 – 17 June 2022  
Organized by the Estonian Biochemical Society 

by the FEBS3+ Meeting programme

We invite you to participate in the FEBS3+ conference 2022 to be held in Tallinn.
Please find the details below. In case of further questions please contact the organizers: febs3plus@biokeemiaselts.ee

Registration, deadlines and fees

Important deadlines   

Deadline for registration, abstract submission and payment for the conference fee is April 15. 

Registration fee   

30 EUR Students (Doctoral, Master and Bachelor students) 
60 EUR Other Participants

The fee includes the conference, abstracts, coffee-breaks, lunches and Gala Dinner.


We cooperate with a ticketing services company Piletikeskus to offer all participants smooth registration and multiple choice payment options.

Please follow the link to register:

NB! All presenters. The title of the presentation and the abstract should be inserted when registering for the event under the registration link. All presenters are asked to carefully follow the instructions described under the section “Information for presenters”.

Conference programme and venue

A detailed programme will be available soon.   

Please note that on June 15 and 16 there will be a full-day and on June 17 a half-day programme.    

The conference will take place in central Tallinn, at the Tallinn University conference centre.

Gala Dinner 

All the participants are invited to join the festive Gala Dinner at 20:00-23:00 on Wednesday, June 15 in the Restaurant Maikrahv, on the Town Hall Square in Old Tallinn. Pre-registration needed.    



  • Dr. Kaisa Marjamaa, Senior researcher, VTT Technical Research Center of Finland “Enzymatic fibre modifications: from fundamentals to applications”  
  • Prof. Angela Ivask, Professor of genetics, University of Tartu “Antimicrobial materials and surface coatings: an effective solution or a matter of concern”
  • Prof. Andres Salumets, University of Tartu (topic related to biochemistry of reproductive medicine)  
  • Prof. Mart Saarma, Institute of Biotechnology, HiLIFE, University of Helsinki, “ER stress regulating CDNF and MANF proteins protect cells by a novel mechanism”  
  • Prof. Peep Palumaa, Tallinn University of Technology (topic related to copper biochemistry)  
  • Prof. Petri-Jaan Lahtvee, Tallinn University of Technology (cell factories, bioengineering)  
  • Prof. Kaspar Valgepea, ERA Chair in Gas Fermentation, University of Tartu, Institute of Technology (gas fermentation, bioengineering)  
  • Dr. Priit Eek, postdoctoral fellow, Pennsylvania State University (structural biology, replication)  
  • Dr. Mart Ustav Jr., CSO of Icosagen Inc. “Inhalation based delivery of therapeutic antibodies against SARS-CoV-2″
  • Prof. Kaspars Tārs, Latvian Biomedical Researh and Study Centre – LBMC, “Structure and applications of ssRNA bacteriophage AP205”  
  • Prof. Kristaps Jaudzems, Latvian Institute of Organic Synthesis – LIOS, “ Structural Analysis of an Antigen Chemically Coupled on Virus-Like Particles”  
  • Prof. Aija Linē, LBMC, “Functional roles of exercise-induced extracellular vesicles in the prevention of cancer”  
  • Dr. pharm. Edgars Liepiņš, prof. Maija Dambrova (LIOS) “Long-chain acylcarnitines: from mitochondrial metabolism to clinical applications”  
  • Dr. chem. Alons Lends, LIOS,  “Functional and pathological amyloid fibrils seen by solid-state NMR spectroscopy”  
  • Dr. biol. Gints Kalniņš, LBMC, “Variety of GRM2 type bacterial microcompartment particles demonstrated by cryo-EM”  
  • Dr. pharm. Edijs Vāvers, LIOS,  “Interaction between sigma-1 chaperone protein and GABA-B receptors: evidence from sigma-1 receptor knockout mice”  
  • Dr. chem. Emilio Parsini, LIOS, “Drugging the undruggable: towards the development of selective modulators of cadherin-mediated cell-cell adhesion”  
  • Dr. biol. Teodors Panteļejevs, LIOS, “A conserved mechanism of interferon signalling antagonism in poxviruses and paramyxoviruses” 
  • Dr. biol. Zane Kalniņa (LBMC). Subject about the role of CAIX in breast cancer progression
  • Dr. biol. Baiba Švalbe (LIOS) “Stealth brush polymers avoid rapid clearance and display effective accumulation in TNBC tumours”
  • Dr. sc. ing. Egils Stalidzāns (UL) Interactions of kinetic and stoichiometric models in the estimation of flux distribution in a metabolic network
  • Dr. biol. Jānis Stāvusis (LBMC) “”MYBPC1 associated myopathy and tremor as a novel disease phenotype” 

FEBS National Lecture will be delivered by Prof. Helgi Schiöth (Uppsala University, Sweden)

Further researchers with PhD, who have confirmed their attendance to conference, but not provided the titles of presentations yet, are:

  • Dr. biol. Jānis Liepiņš (University of Latvia -UL)  
  • Prof. Egils Stalidzāns (UL)  
  • Dr. pharm. Edgars Liepiņš (LIOS)  
  • Prof. Daumantas Matulis, Vilnius University (topic about drug design and drug discovery)  
  • Prof. Vilmantė Borutaitė, University of Health Sciences (topic about molecular mechanisms of cell death in neurodegenerative diseases)  
  • Prof. Rolandas Meškys, Vilnius University. (Topic about biodegradation of orgnic polutants)  
  • Prof. Viaceslav Yurchenko, Czech Republic. (Topic about protozoan viruses)  
  • Prof. Jerka Dumic, Croatian Society of Biochemistry and Molecular Biology
  • Prof. Marc Bauman, Finnish Biobio-Society  

Organizing Committee

Conference Chair

Dr Tiit Lukk, President of the Estonian Biochemical Society, Tallinn University of Technology

Members of Organizing Committee 


  • Prof Ago Rinken, Department of Chemistry, University of Tartu  
  • Dr Helike Lõhelaid, Department of Biotechnology, University of Helsinki  
  • Dr Olga Kukk, Netherlands Cancer Institute  
  • Ms Katrina Laks, Secretary General of the Estonian Biotechnical Society, Tallinn University of Technology  


  • Prof Kaspars Tars, Latvian University, President of the Latvian Biochemical Society  
  • Dr Biol Zane Kalnina, Latvian Biomedical Research and Study Centre, Representative of Latvia to FEBS  
  • Prof Nils Rostoks, Director of Latvian Biomedical Research and Study Centre  


  • Prof Daumantas Matulis, President of the Lithuanian Biochemical Society, Institute of Biotechnology, Vilnius University  
  • Prof Vilmantė Borutaitė, Lithuanian University of Health Sciences  
  • Dr Valeryia Mikalayeva, Institute of Cardiology, Lithuanian University of Health Sciences

Information for presenters

Speakers will be contacted by the societies. Poster presenters are expected to express their interest when registering for the conference.

All presenters are asked to follow the instructions for the authors. Please open the file under the link and follow the instructions.

Please note that the abstracts should be sent under the registration link. The texts of the abstracts will not be edited and will be printed in the conference abstract book as compiled by the authors.

Instructions_to_the_authors_FEBS3+ 2022

Travel and Accommodation

There is a FEBS3+ travel award scheme available to compensate the travel and accommodation expenses of the Students affiliated to the Latvian, Lithuanian and Estonian Biochemical Societies. To apply for the scheme, one will have to keep and present the invoices/receipts as a proof of relevant services used in connection to participation of the FEBS3+ meeting in Tallinn during June 15-17 2022.   

The maximum amount of compensation per awardee:

Travel costs from Latvia and Lithuania according to the ticket/invoice presented.  

Accommodation costs: 85 EUR/per night, for maximum 3 nights/units. In case the (unit) cost will be higher, the cost will be partly compensated.   

Accommodation options with special rates for the FEBS3+ participants

Park Inn by Radisson Central Hotel (3*) 

For the period of June 14-17, 2022 standard rooms, with special rate for the FEBS3+ participants:

  • single 80 EUR
  • twin 85 EUR per night  

Price includes: breakfast and access to the gym.

Special rate can be booked according to the hotel’s availability – e.g. rooms have not been pre-booked, hotel confirms reservations with special agreed price as long as they do have enough available rooms. Reservations can be cancelled free of charge until 24 hrs before the arrival day . 

Reservation link:

Park Inn by Radisson Central Tallin-FEBS22


Parking is for extra charge. Please find attached nearby parking options.
ParkInnCentral parking ENG 2022

The hotel is located within a 10 minute walking distance (700 m) from the conference building. Alternatively take a Tram, lines 1 or 3. 

of FEBS3+ 2022

Aims of the FEBS3+ Meetings Programme  

The FEBS3+ Meetings programme was established by FEBS to support scientific meetings equivalent to an annual national scientific meeting of a Constituent Society but organized through collaboration of at least three FEBS Constituent Societies. The aim of the programme is to increase international collaboration between molecular life scientists in a subset of countries within the FEBS area, such as those in a particular region or linked in other ways, while also encouraging sharing of Society expertise and efforts.  

Funding and event organization  

Events in the FEBS3+ Meetings programme have been approved, at the proposal stage by the FEBS Congress Counsellor, FEBS Secretary General and FEBS Treasurer, for receipt of FEBS grants for the event organization and for supporting the participation of early-career researchers. The FEBS Executive Committee monitors this support programme through means such as reports from organizers and visits to events in progress. 

The development and delivery of the scientific programme of a FEBS3+ meeting, and other management and organization of the event including financial matters and participant data handling, are carried out by the hosting societies and others they appoint. When you register for the event, you are entering an arrangement with the host societies or appointed secretariat. As well as receiving grants from FEBS for the event, FEBS3+ organizers may also secure additional funding from other grant-awarding bodies and sponsors.  

For more information about FEBS, please visit the FEBS website